all patients given ect showed a considerable increase in plasma and rbc haloperidol neuroleptic activities after ect ( % increase in plasma neuroleptic activity , 28-409 % ; mean + sd , 136 +/- 155 % , p less than 0.005 , wilcoxon test ; % increase in rbc neuroleptic activity , 11-121 % ; mean + sd , 59 +/- 40 % , p less than 0.005 ) .
C0018546
haloperidol
C0040615
neuroleptic